15th ISCT Annual Meeting
第15届ISCT年会
基本信息
- 批准号:7743362
- 负责人:
- 金额:$ 0.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAreaCell TherapyCellsCitiesClinicalCommunicationCoronary ArteriosclerosisDiabetes MellitusHematopoietic Stem Cell TransplantationImmunotherapeutic agentIndustryInjuryInvestigationIslet CellLaboratoriesLaboratory PersonnelLiver diseasesMalignant NeoplasmsMedicineMesenchymal Stem CellsMolecularPatientsPhysiciansPublicationsResearchResearch InstituteResearch PersonnelResourcesScientistSocietiesSpinalTherapeutic StudiesTissuesTraining and EducationTranslationsWorkabstractingbasecareercell typeexperiencehigh schoolinnovationinterestmeetingsprofessorprogramssymposiumtherapeutic developmenttumor immunologyuniversity student
项目摘要
DESCRIPTION (provided by applicant):
The ISCT annual meeting is the premier opportunity for those working or interested in cell based therapeutic development to exchange scientific, clinical, technical, commercial, and regulatory information with colleagues from academia, industry, and regulatory agencies around the world. Last year's conference welcomed over 660 delegates from all over the world.
We expect a modest increase again this year and are planning to host over 700 people. To enhance our program, we are adding an interactive Public Session aimed at encouraging high school and college students to pursue careers as researchers and physicians in the area of cellular therapy.
The chairs of this meeting are Dr. Steven Forman, Clinical Director, Division of Cancer Immunotherapeutics and Tumor Immunology, City of Hope and Dr. Bruce Torbett, Associate Professor, Department of Molecular and Experimental Medicine, Scripps Research Institute.
Program Objectives
The objectives of the ISCT annual meeting include: (a) emphasizing the translational aspects of and issues involved with all types of cell and tissue-based research
(b) Encouraging cross-disciplinary participation in Society activities (e.g., membership, publications, educational programs, conferences, etc) from scientists, clinicians, laboratory personnel, regulatory professionals, and others from both academia and industry
(c) Addressing the scientific, clinical, laboratory and regulatory issues related to each type of cell-based research/therapy
(d) facilitating the translation of information and experience from more mature cellular research areas such as hematopoietic stem cell transplantation to other emerging areas including nonhematopoietic areas such as mesenchymal stem cells, islet cells, etc and
(d) Facilitating the transfer of information and experience from senior practicioners to young scientists in the field. (End of Abstract)
描述(由申请人提供):
ISCT年会是那些对基于细胞的治疗开发工作或感兴趣的人的首要机会,可以与世界各地的学术界,工业和监管机构的同事交换科学,临床,技术,商业和监管信息。去年的会议欢迎来自世界各地的660多名代表。
我们预计今年会再次增加,并计划接待700多人。为了增强我们的计划,我们正在添加一个互动公开会议,旨在鼓励高中和大学生从事蜂窝疗法领域的研究人员和医生的职业。
这次会议的主席是癌症免疫治疗和肿瘤免疫学部临床主任史蒂芬·福尔曼(Steven Forman),霍普市和斯克里普斯研究所分子和实验医学系副教授布鲁斯·托尔贝特博士。
程序目标
ISCT年会的目标包括:(a)强调所有类型的细胞和基于组织的研究的翻译方面和问题
(b)从科学家,临床医生,实验室人员,监管专业人员以及学术界和行业的其他人中,鼓励跨学科参与社会活动(例如会员,出版物,教育计划,会议等)
(c)解决与每种基于细胞的研究/治疗相关的科学,临床,实验室和调节问题
(d)促进从更成熟的细胞研究领域的信息和经验的转化,例如造血干细胞移植到其他新兴区域,包括非杂质的区域,例如间充质干细胞,胰岛细胞,等等
(d)促进信息和经验从高级实践者转移到该领域的年轻科学家。 (抽象的结尾)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen J Forman其他文献
Nivolumab Plus ICE As First Salvage Therapy in High-Risk Relapsed/Refractory Hodgkin Lymphoma
- DOI:
10.1182/blood-2022-167626 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Matthew Mei;Joycelynne Palmer;Ni-Chun Tsai;Hun Ju Lee;Iris Isufi;Leslie L. Popplewell;Lynne Smith;Lacolle Peters;Lara Rodriguez;James Godfrey;John H. Baird;Joo Y. Song;Steven T. Rosen;Larry W. Kwak;Stephen J Forman;Alex F. Herrera - 通讯作者:
Alex F. Herrera
Positive Coombs Test in Hodgkin's Disease: Significance and Implications
- DOI:
10.1182/blood.v55.4.607.607 - 发表时间:
1980-04-01 - 期刊:
- 影响因子:
- 作者:
Alexandra M Levine;Phyllis Thornton;Stephen J Forman;Philip Van Hale;Diane Holdorf;Charles L Rouault;Darlene Powars;Donald I Feinstein;Robert J Lukes - 通讯作者:
Robert J Lukes
Multicenter Pilot Clinical Trial of Enasidenib As Maintenance Therapy after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia (AML) Carrying IDH2 Mutations
- DOI:
10.1182/blood-2022-169964 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Amandeep Salhotra;Nelli Bejanyan;Dongyun Yang;Sally Mokhtari;Monzr M. Al Malki;Karamjeet S. Sandhu;Rawan Faramand;Ibrahim Aldoss;Andrew S. Artz;Ahmed Aribi;Hany Elmariah;Firoozeh Sahebi;Joshua Mansour;Brian J Ball;Vaibhav Agrawal;Ling Li;Vinod A. Pullarkat;Stephen J Forman;Guido Marcucci;Ryotaro Nakamura - 通讯作者:
Ryotaro Nakamura
Individual Prediction of Cardiovascular Events in Blood or Marrow Transplant Survivors - a BMT Survivor Study Report
- DOI:
10.1182/blood-2022-167073 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Radhika Gangaraju;Yanjun Chen;Lindsey Hageman;Wendy Landier;Nora Balas;Elizabeth Schlichting;Liton F. Francisco;Alysia Bosworth;Hok Sreng Te;Lennie Wong;Daniel J. Weisdorf;Ravi Bhatia;Stephen J Forman;Saro H. Armenian;Smita Bhatia - 通讯作者:
Smita Bhatia
Frequent Early Geriatric Complications after Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Adults Impairs Disability-Free Survival (DiFS)
- DOI:
10.1182/blood-2022-167174 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Jorge M. Ramos Perez;Haoyue Shan;Dongyun Yang;Leana Cabrera Chien;Carolina Uranga;Jaroslava Salman;Ibrahim Aldoss;Haris Ali;Ahmed Aribi;Saro H. Armenian;Shukaib Arslan;Vinod A. Pullarkat;Amandeep Salhotra;Karamjeet S. Sandhu;Ricardo Spielberger;Anthony S. Stein;Guido Marcucci;Monzr M. Al Malki;Stephen J Forman;William Dale - 通讯作者:
William Dale
Stephen J Forman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen J Forman', 18)}}的其他基金
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
脑室内 (ICV) 施用靶向 CD19 的嵌合抗原受体 (CAR) T 细胞治疗原发性中枢神经系统淋巴瘤
- 批准号:
10522948 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
脑室内 (ICV) 施用靶向 CD19 的嵌合抗原受体 (CAR) T 细胞治疗原发性中枢神经系统淋巴瘤
- 批准号:
10700973 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
图像引导照射安全强化难治性白血病的 HSCT 治疗方案
- 批准号:
9011868 - 财政年份:2015
- 资助金额:
$ 0.8万 - 项目类别:
Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and
基于放射免疫疗法的 B 细胞淋巴瘤和移植治疗方案
- 批准号:
7016807 - 财政年份:2006
- 资助金额:
$ 0.8万 - 项目类别:
CMV/CD19 bi-Specific CAR T cells combined with CMV vaccine as post-transplantation immunotherapy for non-Hodgkin lymphoma
CMV/CD19双特异性CAR T细胞联合CMV疫苗作为非霍奇金淋巴瘤移植后免疫治疗
- 批准号:
10242159 - 财政年份:2004
- 资助金额:
$ 0.8万 - 项目类别:
CMV/CD19 bi-Specific CAR T cells combined with CMV vaccine as post-transplantation immunotherapy for non-Hodgkin lymphoma
CMV/CD19双特异性CAR T细胞联合CMV疫苗作为非霍奇金淋巴瘤移植后免疫治疗
- 批准号:
10456960 - 财政年份:2004
- 资助金额:
$ 0.8万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce
从根本上解决手术差异;
- 批准号:
10639471 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Protein Phosphorylation Networks in Health and Disease
健康和疾病中的蛋白质磷酸化网络
- 批准号:
10682983 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别: